Matches in Nanopublications for { ?s ?p "noxafil is an azole antifungal agent indicated for injection delayed release tablets and oral suspension prophylaxis of invasive aspergillus candida 1 1 oral suspension treatment of oropharyngeal candidiasis opc including opc refractory ropc to itraconazole and or fluconazole 1 2 noxafil r aspergillus candida noxafil injection is indicated in patients 18 years of age and older noxafil delayed release tablets and oral suspension are indicated in patients 13 years of age and older noxafil oral suspension is indicated for the treatment of oropharyngeal candidiasis including oropharyngeal candidiasis refractory to itraconazole and or fluconazole" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label "noxafil is an azole antifungal agent indicated for injection delayed release tablets and oral suspension prophylaxis of invasive aspergillus candida 1 1 oral suspension treatment of oropharyngeal candidiasis opc including opc refractory ropc to itraconazole and or fluconazole 1 2 noxafil r aspergillus candida noxafil injection is indicated in patients 18 years of age and older noxafil delayed release tablets and oral suspension are indicated in patients 13 years of age and older noxafil oral suspension is indicated for the treatment of oropharyngeal candidiasis including oropharyngeal candidiasis refractory to itraconazole and or fluconazole" assertion.